Statistics for The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y<sub>1</sub> receptor antagonists
Total visits
| views | |
|---|---|
| The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y<sub>1</sub> receptor antagonists | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |